Delayed Treatment Effects of Xanthine Oxidase Inhibition on Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction

被引：14

作者：

Xu, X. ^{[1
,2
]}

Zhao, L. ^{[3
]}

Hu, X. ^{[1
,2
]}

Zhang, P. ^{[1
,2
]}

Wessale, J. ^{[3
]}

Bache, R. ^{[1
,2
]}

Chen, Y. ^{[1
,2
]}

机构：

[1] Univ Minnesota, Ctr Vasc Biol, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA

[3] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA

来源：

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS | 2010年 / 29卷 / 4-6期

关键词：

Febuxostat; allopurinol; heart failure; left ventricular dysfunction; INDUCED HEART-FAILURE; MYOCARDIAL-INFARCTION; CARDIOMYOPATHY; FEBUXOSTAT; EFFICIENCY; DOGS;

D O I：

10.1080/15257771003738683

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The nonpurine selective xanthine oxidase (XO) inhibitor febuxostat attenuates development of left ventricular (LV) hypertrophy and dysfunction in mice when treatment is initiated within 1 hour of transverse aortic constriction (TAC). This study investigated whether a 7-day delay of treatment with the XO inhibitors febuxostat or allopurinol would reverse TAC-induced changes after onset of heart failure (HF). Neither treatment significantly affected TAC-induced LV hypertrophy; only febuxostat caused a modest improvement in LV function (10% increase in LV ejection fraction). However, the purine analog allopurinol tended to increase mortality compared with vehicle or febuxostat in HF mice.

引用

页码：306 / 313

页数：8

共 50 条

[41] Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction [J].

Xu, Xin ;

Fassett, John ;

Hu, Xinli ;

Zhu, Guangshuo ;

Lu, Zhongbing ;

Li, Yunfang ;

Schnermann, Jurgen ;

Bache, Robert J. ;

Chen, Yingjie .

HYPERTENSION, 2008, 51 (06) :1557-1564

[42] Left Ventricular Systolic Dysfunction Induced by Ventricular Ectopy A Novel Model for Premature Ventricular Contraction-Induced Cardiomyopathy [J].

Huizar, Jose F. ;

Kaszala, Karoly ;

Potfay, Jonathan ;

Minisi, Anthony J. ;

Lesnefsky, Edward J. ;

Abbate, Antonio ;

Mezzaroma, Eleonora ;

Chen, Qun ;

Kukreja, Rakesh C. ;

Hoke, Nicholas N. ;

Thacker, Leroy R., II ;

Ellenbogen, Kenneth A. ;

Wood, Mark A. .

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2011, 4 (04) :543-U231

[43] Exercise-Induced Left Ventricular Systolic Dysfunction in Women Heterozygous for Dystrophinopathy [J].

Weiss, Robert M. ;

Kerber, Richard E. ;

Jones, Jane K. ;

Stephan, Carrie M. ;

Trout, Christina J. ;

Lindower, Paul D. ;

Staffey, Kimberly S. ;

Campbell, Kevin P. ;

Mathews, Katherine D. .

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2010, 23 (08) :848-853

[44] Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction [J].

Docherty, Kieran F. ;

Campbell, Ross T. ;

Brooksbank, Katriona J. M. ;

Dreisbach, John G. ;

Forsyth, Paul ;

Godeseth, Rosemary L. ;

Hopkins, Tracey ;

Jackson, Alice M. ;

Lee, Matthew M. Y. ;

McConnachie, Alex ;

Roditi, Giles ;

Squire, Iain B. ;

Stanley, Bethany ;

Welsh, Paul ;

Jhund, Pardeep S. ;

Petrie, Mark C. ;

McMurray, John J. V. .

CIRCULATION, 2021, 144 (03) :199-209

[45] Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway [J].

Hsu, Steven ;

Nagayama, Takahiro ;

Koitabashi, Norimichi ;

Zhang, Manling ;

Zhou, Liye ;

Bedja, Djahida ;

Gabrielson, Kathleen L. ;

Molkentin, Jeffery D. ;

Kass, David A. ;

Takimoto, Eiki .

CARDIOVASCULAR RESEARCH, 2009, 81 (02) :301-309

[46] TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice [J].

Wang, Zhen ;

Xu, Yao ;

Wang, Menglong ;

Ye, Jing ;

Liu, Jianfang ;

Jiang, Huimin ;

Ye, Di ;

Wan, Jun .

EBIOMEDICINE, 2018, 36 :54-62

[47] Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction [J].

Heggermont, Ward A. ;

Papageorgiou, Anna-Pia ;

Quaegebeur, Annelies ;

Deckx, Sophie ;

Carai, Paolo ;

Verhesen, Wouter ;

Eelen, Guy ;

Schoors, Sandra ;

van Leeuwen, Rick ;

Alekseev, Sergey ;

Elzenaar, Ies ;

Vinckier, Stefan ;

Pokreisz, Peter ;

Walravens, Ann-Sophie ;

Gijsbers, Rik ;

Van Den Haute, Chris ;

Nickel, Alexander ;

Schroen, Blanche ;

van Bilsen, Marc ;

Janssens, Stefan ;

Maack, Christoph ;

Pinto, Yigal ;

Carmeliet, Peter ;

Heymans, Stephane .

CIRCULATION, 2017, 136 (08) :747-+

[48] USP38 exacerbates pressure overload-induced left ventricular electrical remodeling [J].

Pan, Yucheng ;

Xiao, Zheng ;

Yang, Hongjie ;

Kong, Bin ;

Meng, Hong ;

Shuai, Wei ;

Huang, He .

MOLECULAR MEDICINE, 2024, 30 (01)

[49] Mitochondrial Integrity and Function in the Progression of Early Pressure Overload-Induced Left Ventricular Remodeling [J].

Chaanine, Antoine H. ;

Nair, K. Sreekumaran ;

Bergen, Robert H., III ;

Klaus, Katherine ;

Guenzel, Adam J. ;

Hajjar, Roger J. ;

Redfield, Margaret M. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (06)

[50] Glucose-6-Phosphate Dehydrogenase Deficiency Promotes Susceptibility to Pressure Overload Induced Left Ventricular Dysfunction and Hypertrophy [J].

Hecker, Peter A. ;

Ribeiro, Rogerio F., Jr. ;

Brown, Bethany H. ;

O'Connell, Kelly ;

Stanley, William C. .

CIRCULATION, 2011, 124 (21)

← 1 2 3 4 5 →